Clinical Trials Logo

2,3-Bisphosphoglycerate clinical trials

View clinical trials related to 2,3-Bisphosphoglycerate.

Filter by:
  • None
  • Page 1

NCT ID: NCT04192578 Not yet recruiting - Clinical trials for 2,3-Bisphosphoglycerate

Effect of RIC on 2,3-BPG in Erythrocyte (RIC-BPG)

Start date: January 15, 2021
Phase: N/A
Study type: Interventional

Under hypoxia or high-altitude hypoxia ,it has been found that 2,3-bisphosphoglycerate(2,3-BPG) in erythrocyte increased and facilitated oxygen release to tissues.Remote Ischemic Conditioning(RIC) can also cause hypoxic conditions in local limbs.Thus,we hypothesize that whether RIC could also increase 2,3-BPG in erythrocyte.